You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NEWS / EVENTS / .........

EVENTS - 27-04-2017

Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017

Kedrion Biopharma joins IPOPI - International Patient Organization for Primary Immunodeficiencies in celebrating World PI Week 2017, reaffirming the principles that underlie the partnership between company and international association: to extend awareness and to improve diagnosis and treatment of primary immunodeficiencies the world over.

World PI Week is celebrated globally from 22-29 April 2017 and IPOPI is one of the key organizations supporting the campaign. The association has recently issued a scientific editorial highlighting the need to ensure access to immunoglobulin therapies for patients with primary immunodeficiency, thereby improving their quality of life and the sustainability of healthcare systems. Read the article here.

Kedrion is a long-standing partner of IPOPI and works alongside this association to increase access to early diagnosis and optimal treatments for PID in target countries. Watch IPOPI speak of joint initiatives for doctors and patients in Vietnam and Philippines at ESID 2016.

For more information please contact: